Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.13 Billion CNY | -12.07% |
| 2022 | 1.26 Billion CNY | -8.85% |
| 2021 | 1.38 Billion CNY | 27.92% |
| 2020 | 1.08 Billion CNY | -11.0% |
| 2019 | 1.21 Billion CNY | 7.84% |
| 2018 | 1.12 Billion CNY | 7.98% |
| 2017 | 1.04 Billion CNY | -1.04% |
| 2016 | 1.05 Billion CNY | -10.4% |
| 2015 | 1.17 Billion CNY | 15.83% |
| 2014 | 1.01 Billion CNY | 47.73% |
| 2013 | 689.16 Million CNY | 465.31% |
| 2012 | 121.9 Million CNY | 4.2% |
| 2011 | 116.99 Million CNY | 50.25% |
| 2010 | 77.86 Million CNY | 52.22% |
| 2009 | 51.15 Million CNY | 13.13% |
| 2008 | 45.21 Million CNY | 6.49% |
| 2007 | 42.46 Million CNY | 25.77% |
| 2006 | 33.76 Million CNY | -8.3% |
| 2005 | 36.81 Million CNY | -31.52% |
| 2004 | 53.76 Million CNY | 302.21% |
| 2003 | 13.36 Million CNY | 662.91% |
| 2002 | 1.75 Million CNY | -89.38% |
| 2001 | 16.49 Million CNY | -45.81% |
| 2000 | 30.43 Million CNY | 63.68% |
| 1999 | 18.59 Million CNY | -34.17% |
| 1998 | 28.24 Million CNY | -35.32% |
| 1997 | 43.66 Million CNY | 33.84% |
| 1996 | 32.62 Million CNY | 20.38% |
| 1995 | 27.1 Million CNY | -87.33% |
| 1994 | 213.86 Million CNY | 303.57% |
| 1993 | 52.99 Million CNY | 37.4% |
| 1992 | 38.56 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 243.59 Million CNY | -10.63% |
| 2024 Q3 | 230.71 Million CNY | -2.34% |
| 2024 Q1 | 272.57 Million CNY | 1.25% |
| 2023 Q3 | 248.34 Million CNY | -23.41% |
| 2023 Q1 | 312.9 Million CNY | 0.5% |
| 2023 Q2 | 324.26 Million CNY | 3.63% |
| 2023 FY | 1.11 Billion CNY | -12.07% |
| 2023 Q4 | 269.2 Million CNY | 8.4% |
| 2022 Q4 | 311.36 Million CNY | 0.7% |
| 2022 Q2 | 320.96 Million CNY | -0.37% |
| 2022 Q3 | 309.18 Million CNY | -3.67% |
| 2022 FY | 1.26 Billion CNY | -8.85% |
| 2022 Q1 | 322.16 Million CNY | -13.71% |
| 2021 Q2 | 354.24 Million CNY | 11.96% |
| 2021 Q1 | 316.41 Million CNY | -0.16% |
| 2021 FY | 1.38 Billion CNY | 27.92% |
| 2021 Q3 | 342.31 Million CNY | -3.37% |
| 2021 Q4 | 373.36 Million CNY | 9.07% |
| 2020 Q1 | 169.96 Million CNY | -53.54% |
| 2020 Q2 | 294.45 Million CNY | 73.25% |
| 2020 Q3 | 302.4 Million CNY | 2.7% |
| 2020 Q4 | 316.92 Million CNY | 4.8% |
| 2020 FY | 1.08 Billion CNY | -11.0% |
| 2019 FY | 1.21 Billion CNY | 7.84% |
| 2019 Q4 | 365.8 Million CNY | 19.9% |
| 2019 Q3 | 305.08 Million CNY | -0.22% |
| 2019 Q2 | 305.75 Million CNY | 26.84% |
| 2019 Q1 | 241.04 Million CNY | -41.55% |
| 2018 Q3 | 241.96 Million CNY | -17.66% |
| 2018 Q4 | 412.39 Million CNY | 70.44% |
| 2018 FY | 1.12 Billion CNY | 7.98% |
| 2018 Q1 | 180.98 Million CNY | -51.2% |
| 2018 Q2 | 293.84 Million CNY | 62.36% |
| 2017 Q2 | 229.79 Million CNY | 36.86% |
| 2017 Q3 | 277.14 Million CNY | 20.61% |
| 2017 Q4 | 370.89 Million CNY | 33.82% |
| 2017 FY | 1.04 Billion CNY | -1.04% |
| 2017 Q1 | 167.9 Million CNY | -58.67% |
| 2016 Q3 | 228.82 Million CNY | -12.56% |
| 2016 Q2 | 261.7 Million CNY | 63.69% |
| 2016 FY | 1.05 Billion CNY | -10.4% |
| 2016 Q4 | 406.28 Million CNY | 77.56% |
| 2016 Q1 | 159.87 Million CNY | -62.16% |
| 2015 Q2 | 263.95 Million CNY | 18.25% |
| 2015 Q1 | 223.22 Million CNY | -30.23% |
| 2015 FY | 1.17 Billion CNY | 15.83% |
| 2015 Q4 | 422.5 Million CNY | 56.71% |
| 2015 Q3 | 269.61 Million CNY | 2.15% |
| 2014 Q4 | 319.93 Million CNY | 24.67% |
| 2014 FY | 1.01 Billion CNY | 47.73% |
| 2014 Q2 | 247.23 Million CNY | 27.24% |
| 2014 Q1 | 194.3 Million CNY | -33.4% |
| 2014 Q3 | 256.62 Million CNY | 3.8% |
| 2013 Q3 | 208.09 Million CNY | 23.08% |
| 2013 FY | 689.16 Million CNY | 465.31% |
| 2013 Q4 | 291.75 Million CNY | 40.2% |
| 2013 Q1 | 20.24 Million CNY | -55.62% |
| 2013 Q2 | 169.06 Million CNY | 734.93% |
| 2012 Q2 | 37.03 Million CNY | 111.17% |
| 2012 Q3 | 21.7 Million CNY | -41.39% |
| 2012 Q4 | 45.62 Million CNY | 110.18% |
| 2012 FY | 121.9 Million CNY | 4.2% |
| 2012 Q1 | 17.53 Million CNY | -50.34% |
| 2011 FY | 116.99 Million CNY | 50.25% |
| 2011 Q4 | 35.32 Million CNY | 30.07% |
| 2011 Q3 | 27.15 Million CNY | -20.52% |
| 2011 Q2 | 34.16 Million CNY | 67.83% |
| 2011 Q1 | 20.35 Million CNY | 44.9% |
| 2010 Q3 | 23.24 Million CNY | -25.36% |
| 2010 Q1 | 9.42 Million CNY | -35.98% |
| 2010 Q2 | 31.14 Million CNY | 230.55% |
| 2010 FY | 77.86 Million CNY | 52.22% |
| 2010 Q4 | 14.04 Million CNY | -39.57% |
| 2009 Q2 | 19.71 Million CNY | 388.62% |
| 2009 FY | 51.15 Million CNY | 13.13% |
| 2009 Q4 | 14.71 Million CNY | 16.0% |
| 2009 Q3 | 12.68 Million CNY | -35.63% |
| 2009 Q1 | 4.03 Million CNY | -42.03% |
| 2008 Q3 | 20.63 Million CNY | 65.56% |
| 2008 FY | 45.21 Million CNY | 6.49% |
| 2008 Q1 | 5.16 Million CNY | -23.22% |
| 2008 Q2 | 12.46 Million CNY | 141.28% |
| 2008 Q4 | 6.95 Million CNY | -66.27% |
| 2007 Q1 | 4.55 Million CNY | -4.21% |
| 2007 Q4 | 6.72 Million CNY | -54.8% |
| 2007 Q3 | 14.88 Million CNY | -8.68% |
| 2007 Q2 | 16.29 Million CNY | 258.0% |
| 2007 FY | 42.46 Million CNY | 25.77% |
| 2006 Q2 | 12.25 Million CNY | 182.46% |
| 2006 Q3 | 12.41 Million CNY | 1.34% |
| 2006 Q4 | 4.75 Million CNY | -61.73% |
| 2006 FY | 33.76 Million CNY | -8.3% |
| 2006 Q1 | 4.33 Million CNY | 266.8% |
| 2005 Q4 | 1.18 Million CNY | -88.44% |
| 2005 Q1 | 9.55 Million CNY | -43.79% |
| 2005 Q2 | 15.85 Million CNY | 65.93% |
| 2005 Q3 | 10.23 Million CNY | -35.45% |
| 2005 FY | 36.81 Million CNY | -31.52% |
| 2004 FY | 53.76 Million CNY | 302.21% |
| 2004 Q1 | 4.1 Million CNY | -20.6% |
| 2004 Q2 | 23.79 Million CNY | 479.59% |
| 2004 Q3 | 8.86 Million CNY | -62.73% |
| 2004 Q4 | 16.99 Million CNY | 91.64% |
| 2003 Q2 | 3.01 Million CNY | 115.41% |
| 2003 Q4 | 5.17 Million CNY | 36.49% |
| 2003 Q1 | 1.39 Million CNY | 818.91% |
| 2003 Q3 | 3.78 Million CNY | 25.81% |
| 2003 FY | 13.36 Million CNY | 662.91% |
| 2002 Q3 | 950.14 Thousand CNY | 15.48% |
| 2002 FY | 1.75 Million CNY | -89.38% |
| 2002 Q1 | 173.63 Thousand CNY | 0.0% |
| 2002 Q2 | 822.81 Thousand CNY | 373.88% |
| 2002 Q4 | -194.43 Thousand CNY | -120.46% |
| 2001 FY | 16.49 Million CNY | -45.81% |
| 2000 FY | 30.43 Million CNY | 63.68% |
| 1999 FY | 18.59 Million CNY | -34.17% |
| 1998 FY | 28.24 Million CNY | -35.32% |
| 1997 FY | 43.66 Million CNY | 33.84% |
| 1996 FY | 32.62 Million CNY | 20.38% |
| 1995 FY | 27.1 Million CNY | -87.33% |
| 1994 FY | 213.86 Million CNY | 303.57% |
| 1993 FY | 52.99 Million CNY | 37.4% |
| 1992 FY | 38.56 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 19.29 Billion CNY | 94.098% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 4.59 Billion CNY | 75.238% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.89 Billion CNY | 70.779% |
| Aurora Optoelectronics Co.,Ltd. | -319.56 Million CNY | 456.365% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 23.41 Million CNY | -4764.055% |
| NanJing Pharmaceutical Company Limited | 3.31 Billion CNY | 65.629% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 936.59 Million CNY | -21.592% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 2.45 Billion CNY | 53.6% |